4-55965812-AAAG-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PM4_SupportingBP6BS1BS2

The NM_025009.5(CEP135):​c.1004_1006delAAG​(p.Glu335del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0021 in 1,613,760 control chromosomes in the GnomAD database, including 13 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 12 hom. )

Consequence

CEP135
NM_025009.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 8.63
Variant links:
Genes affected
CEP135 (HGNC:29086): (centrosomal protein 135) This gene encodes a centrosomal protein, which acts as a scaffolding protein during early centriole biogenesis, and is also required for centriole-centriole cohesion during interphase. Mutations in this gene are associated with autosomal recessive primary microcephaly-8. [provided by RefSeq, Jun 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_025009.5. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 4-55965812-AAAG-A is Benign according to our data. Variant chr4-55965812-AAAG-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 210672.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00209 (318/152346) while in subpopulation NFE AF= 0.00237 (161/68032). AF 95% confidence interval is 0.00207. There are 1 homozygotes in gnomad4. There are 178 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP135NM_025009.5 linkc.1004_1006delAAG p.Glu335del disruptive_inframe_deletion Exon 8 of 26 ENST00000257287.5 NP_079285.2 Q66GS9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP135ENST00000257287.5 linkc.1004_1006delAAG p.Glu335del disruptive_inframe_deletion Exon 8 of 26 1 NM_025009.5 ENSP00000257287.3 Q66GS9-1
CEP135ENST00000506202.1 linkn.954_956delAAG non_coding_transcript_exon_variant Exon 1 of 19 1
CEP135ENST00000515081.1 linkn.638_640delAAG non_coding_transcript_exon_variant Exon 5 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.00210
AC:
319
AN:
152228
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.00922
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00631
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00237
Gnomad OTH
AF:
0.00574
GnomAD3 exomes
AF:
0.00267
AC:
670
AN:
250710
Hom.:
2
AF XY:
0.00258
AC XY:
350
AN XY:
135584
show subpopulations
Gnomad AFR exome
AF:
0.000495
Gnomad AMR exome
AF:
0.00165
Gnomad ASJ exome
AF:
0.00775
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00144
Gnomad FIN exome
AF:
0.00698
Gnomad NFE exome
AF:
0.00268
Gnomad OTH exome
AF:
0.00459
GnomAD4 exome
AF:
0.00210
AC:
3063
AN:
1461414
Hom.:
12
AF XY:
0.00210
AC XY:
1529
AN XY:
726996
show subpopulations
Gnomad4 AFR exome
AF:
0.00102
Gnomad4 AMR exome
AF:
0.00181
Gnomad4 ASJ exome
AF:
0.00739
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00136
Gnomad4 FIN exome
AF:
0.00732
Gnomad4 NFE exome
AF:
0.00175
Gnomad4 OTH exome
AF:
0.00346
GnomAD4 genome
AF:
0.00209
AC:
318
AN:
152346
Hom.:
1
Cov.:
32
AF XY:
0.00239
AC XY:
178
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.000385
Gnomad4 AMR
AF:
0.00176
Gnomad4 ASJ
AF:
0.00922
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.00631
Gnomad4 NFE
AF:
0.00237
Gnomad4 OTH
AF:
0.00568
Alfa
AF:
0.000839
Hom.:
0
Bravo
AF:
0.00185
EpiCase
AF:
0.00245
EpiControl
AF:
0.00344

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 13, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Uncertain:1
Sep 04, 2014
Genetic Services Laboratory, University of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

CEP135-related disorder Benign:1
May 20, 2019
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs374626758; hg19: chr4-56831978; API